China Medical System (00867） Obtained Exclusive License of a First-line Phosphate-lowering Drug Velphoro®

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.